Search results
Tryptamine Therapeutics doses first subject in IV-infused psilocin trial
Clinical Trials Arena· 1 day agoA lead programme of Tryp, TRP-8803 is set to address several limitations of oral psilocybin therapy....
Atossa Therapeutics updates protocol for breast cancer treatment trial
Clinical Trials Arena· 1 day agoIn addition to the dose increase, the combination trial will now include around 80 participants...
The cost of solar: rate increases, political feuds and the long-term outlook
Maine Morning Star· 2 days agoMaine residential and business utility customers will start to see increases in their energy bills...
From sheep camp to the city to study uranium’s damage to Navajo people
Source New Mexico· 2 days agoNEW YORK — Every summer as a kid, Kevin Patterson, 29, hiked up the Lukachukai-Ch’ooshgai Mountains,...
Fireworks, Declaration of Independence readings highlight July 4th in Newport County
The Newport Daily News· 2 days agoFollowing the reading, the Artillery Company of Newport will fire a 21 Gun Salute in Washington...
CAMS aims to be both payment aggregator & gateway, expand into education: MD
The Economic Times· 2 days agoAnuj Kumar, MD & CEO, CAMS, says at the CAMS level, they have about 75% share in net equity sales,...
Mitsubishi Pajero and Mahindra Thars' off-roading trip to Sandakphu | Team-BHP
Team-BHP· 2 days agoGot a post from Adhiraj Singh, the man behind our KO group. 12th of March, I enquired again and to...
Allied Blenders IPO: Company may list with 20% premium on July 2
CNBC Awaaz· 2 days agoAllied Blenders and Distillers is likely to make a positive start on its market debut on the bourses...
MC Exclusive | TReDS platform M1xchange to soon get Tata AIG Insurance, SBI General Life on invoice...
CNBC Awaaz· 2 days agoAmazon-backed Trade Receivables electronic Discounting System (TReDS) platform M1xchange will soon...
Mint Explainer: Impact of Sebi steps on single stock derivatives, delisting
Livemint· 2 days agoMint takes a closer look at these decisions and their impact. Sebi revised the eligibility criteria...